Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
Sign Up to like & getrecommendations! Published in 2023 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2022-005809
Abstract: Background Cancer of unknown primary (CUP) is a heterogeneous group of metastatic cancers where a primary tissue of origin (TOO) is uncertain. Most patients with CUP have limited treatment options and poor survival outcomes. Immune… read more here.
Keywords: unknown primary; patients cup; immune genomic; cancer unknown ... See more keywords